Heterogeneous Presentations at Admission But Similar Treatment Response Across Latent Profiles of ARFID Prototypes in Children and Adolescents
European Eating Disorders Review · 2026
DOI: 10.1002/erv.70024 ↗At a glance
Journal article in European Eating Disorders Review, 2026. Written by Sophie R Abber and 10 co-authors. Institution: Department of Psychology, Florida State University, Tallahassee, Florida, USA. Major MEDLINE topics: Avoidant Restrictive Food Intake Disorder. Cited 5 times so far (Crossref); 50 references.
Topics: Kinderkrankenpflege
Abstract (original language)
Background
Avoidant/restrictive food intake disorder (ARFID) is defined by any combination of three prototypic motivations for dietary restriction (sensory‐based avoidance, lack of interest, fear of aversive consequences), resulting in heterogeneous presentations. Some work suggests overlap of prototypes, but little is known about how prototypes cluster together. Further, little research exists on how prototype influences outcome.
Methods
We applied latent profile analysis (LPA) to 159 treatment‐seeking children and adolescents (ages 9–18, 63% female, 78% White) with ARFID using items assessing ARFID prototype on the Eating Disorders in Youth‐Questionnaire (EDY‐Q). Resulting profiles were compared on clinical presentation and change in ARFID, anxiety, and depressive symptoms following evidence‐based higher‐level‐of‐care treatment.
Results
ARFID prototypes present heterogeneously. A 4‐profile solution emerged from the LPA: ARFID‐1 (with fear of aversive consequences; n = 26); ARFID‐2 (with sensory‐based avoidance and lack of interest; n = 43); ARFID‐3 (with all three prototypes; n = 44); and Non‐Endorsers ( n = 53). While profiles differed on ARFID, anxiety, and depressive symptoms at admission, change in symptoms was similar across profiles.
Conclusions
ARFID prototypes frequently overlap. Despite heterogeneity of ARFID prototypes, treatment outcome was similar across latent profiles, supporting continued categorisation of all these motivations for restrictive eating as ARFID. Future work is needed to further validate these profiles.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychology, Florida State University, Tallahassee, Florida, USA.
- University of Novi Sad Faculty of Philosophy, Novi Sad, Serbia.
- Eating Recovery Center, Denver, Colorado, USA.
- Pathlight Mood and Anxiety Center, Denver, Colorado, USA.
- ACUTE at Denver Health, Denver, Colorado, USA.
- Department of Psychiatry and Behavioral Sciences, Northwestern University, Evanston, Illinois, USA.
ORCID profiles: Mina Velimirović, Jamie Manwaring, Renee Rienecke, Daniel Le Grange, Dan V Blalock, Philip S Mehler
Cite
APA
Abber, S. R., Velimirović, M., Sigel, A. N., Duffy, A., Manwaring, J., Rienecke, R., Le Grange, D., Blalock, D. V., Mehler, P. S., Riddle, M., & Joiner, T. E. (2026). Heterogeneous Presentations at Admission But Similar Treatment Response Across Latent Profiles of ARFID Prototypes in Children and Adolescents. European Eating Disorders Review. https://doi.org/10.1002/erv.70024
Vancouver
Abber SR, Velimirović M, Sigel AN, Duffy A, Manwaring J, Rienecke R, et al. Heterogeneous Presentations at Admission But Similar Treatment Response Across Latent Profiles of ARFID Prototypes in Children and Adolescents. European Eating Disorders Review. 2026. doi:10.1002/erv.70024
BibTeX
@article{Abber2026,
author = {Abber, Sophie R and Velimirović, Mina and Sigel, Anika N and Duffy, Alan and Manwaring, Jamie and Rienecke, Renee and Le Grange, Daniel and Blalock, Dan V and Mehler, Philip S and Riddle, Megan and Joiner, Thomas E},
title = {Heterogeneous Presentations at Admission But Similar Treatment Response Across Latent Profiles of ARFID Prototypes in Children and Adolescents},
journal = {European Eating Disorders Review},
year = {2026},
doi = {10.1002/erv.70024}
}
EUVIMED